OracleBio will take part in the Life Science Trade Mission to Switzerland, which takes place from the 14th to 15th of May in Basel & Geneva, Switzerland.
OracleBio is a leading digital pathology services CRO with in-depth expertise in quantitative histopathology techniques to support Pharmaceutical R&D. With extensive experience of quantifying immune cell numbers, biomarker expression and therapeutic proof of mechanism read-outs within pre-clinical and clinical tissue, we deliver detailed cell-by-cell data for improved decision making within R&D. OracleBio uses AI image analysis approaches to extract quantitative data from histopathology samples, delivering reproducible data applicable to statistical analysis. In the field of immuno-oncology, our multiplex data can be used to quantify the action of therapies on the invasion, activation and spatial distribution of immune cells within tumour tissue. Click here to find out more information about how our services can support your pre-clinical and clinical R&D.
The Mission will visit 2 major life science clusters in Switzerland: Basel and Geneva. The focus of this trade mission is to support UK businesses to access key decision-makers in Swiss pharma/biotech companies and to facilitate conversations with a potential customer-base in Switzerland. It is anticipated that the UK delegation will be limited to 15 businesses with a similar number of Swiss pharma/biotech at each location. To find out more about the Life Science Trade Mission to Switzerland, please click here.
Hannah Thomson, OracleBio’s Business Development Manager, will be in attendance. If you would like to learn more about OracleBio’s services, or wish to arrange a time to speak with Hannah during the event, please contact us.